Assessment the Cancer Risk of Indeterminate Thyroid Nodules Through Integration of Clinical, Ultrasonographic and Multiomic Features

Indeterminate thyroid nodules have a mild risk of malignancy (15-30%). The aim of our study is to individuate new biomarkers of thyroid carcinoma through multiomic analyses of blood samples and of specimen samples of patients with indeterminate thyroid nodules.

NCT Number	NCT05428371
Lead Sponsor	University of Cagliari Collaborators: Prof. Pietro Giorgio Calò, Dott. Gian Luigi Canu
Conditions	Thyroid Nodule, Thyroid Cancer
Enrollment	256 participants
Start Date	2023-01-01
Primary Completion	2027-05-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2022-06-23